Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines

Journal of Immunology

Volumn 170, Issue 6, 2003, Pages 3125-3133

  Györy, Ildikó ^a   Fejér, György ^a,c   Ghosh, Nilanjan ^a   Seto, Ed ^a   Wright, Kenneth L ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; HISTONE DEACETYLASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MUTANT PROTEIN; POSITIVE REGULATORY DOMAIN I BINDING FACTOR 1; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX 5; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CANCER CELL CULTURE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; GENE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; MYELOMA CELL; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; POSITIVE REGULATORY DOMAIN ZINC FINGER PROTEIN 1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RNA ANALYSIS; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0037443482     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.6.3125     Document Type: Article

References (58)

1. Angelin-Duclos, C., G. Cattoretti, K. I. Lin, and K. Calame. 2000. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165:5462.
2. Turner, C. A., Jr., D. H. Mack, and M. M. Davis. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77:297.
3. Messika, E. J., P. S. Lu, Y. J. Sung, T. Yao, J. T. Chi, Y. H. Chien, and M. M. Davis. 1998. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J. Exp. Med. 188:515.
4. Lin, Y., K. Wong, and K. Calame. 1997. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 276:596.
5. Gupta, S., A. Anthony, and A. B. Pernis. 2001. Stage-specific modulation of IFN-regulatory factor 4 function by Kruppel-type zinc finger proteins. J. Immunol. 166-6104.
6. Lin, K. I., C. Angelin-Duclos, T. C. Kuo, and K. Calame. 2002. Blimp-1-dependent repression of pax-5 is required for differentiation of B cells to immunoglobulin m-secreting plasma cells. Mol. Cell. Biol. 22:4771.
7. Piskurich, J. F., K. I. Lin, Y. Lin, Y. Wang, J. P. Ting, and K. Calame. 2000. BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat. Immunol. 1:526.
8. Ghosh, N., I. Gyory, G. Wright, J. Wood, and K. L. Wright. 2001. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells. J. Biol. Chem. 276:15264.
9. Lin, K. I., Y. Lin, and K. Calame. 2000. Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro. Mol. Cell. Biol. 20:8684.
10. Keller, A. D., and T. Maniatis. 1991. Identification and characterization of a novel repressor of β-interferon gene expression. Genes Dev. 5:868.
11. Keller, A. D., and T. Maniatis. 1992. Only two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA binding. Mol. Cell. Biol. 12:1940.
12. Abel, K. J., L. C. Brody, J. M. Valdes, M. R. Erdos, D. R. McKinley, L. H. Castilla, S. D. Merajver, F. J. Couch, L. S. Friedman, E. A. Ostermeyer, et al. 1996. Characterization of EZH1, a human homolog of Drosophila enhancer of zeste near BRCA1. Genomics 37:161.
13. Jenuwein, T., G. Laible, R. Dorn, and G. Reuter. 1998. SET domain proteins modulate chromatin domains in eu- and heterochromatin. Cell. Mol. Life Sci. 54:80.
14. Firestein, R., X. Cui, P. Huie, and M. L. Cleary. 2000. Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9. Mol. Cell. Biol. 20:4900.
15. Yang, X. H., and S. Huang. 1999. PFM1 (PRDM4), a new member of the PR-domain family, maps to a tumor suppressor locus on human chromosome 12q23-q24.1. Genomics 61:319.
16. Mock, B. A., L. Liu, D. LePaslier, and S. Huang. 1996. The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10. Genomics 37:24.
17. Fang, W., Z. Piao, D. Simon, J. C. Sheu, and S. Huang. 2000. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Genes Chromosomes Cancer 28:269.
18. Jiang, G., L. Liu, I. M. Buyse, D. Simon, and S. Huang. 1999. Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int. J. Cancer 83:541.
19. Chadwick, R. B., G. L. Jiang, G. A. Bennington, B. Yuan, C. K. Johnson, M. W. Stevens, T. H. Niemann, P. Peltomaki, S. Huang, and A. de la Chapelle. 2000. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc. Natl. Acad. Sci. USA 97:2662.
20. Steele-Perkins, G. F. W., X. H. Yang, M. Van Gele, T. Carling, J. Gu, I. M. Buyse, J. A. Fletcher, J. Liu, R. Bronson, R. B. Chadwick, et al. 2001. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev. 15:2250.
21. Ohyashiki, J. H., K. Ohyashiki, T. Shimamoto, K. Kawakubo, T. Fujimura, S. Nakazawa, and K. Toyama. 1995. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression. Blood 85:3713.
22. Ren, B., K. J. Chee, T. H. Kim, and T. Maniatis. 1999. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev. 13:125.
23. Yu, J., C. Angelin-Duclos, J. Greenwood, J. Liao, and K. Calame. 2000. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol. Cell. Biol. 20:2592.
24. Chen, G., J. Fernandez, S. Mische, and A. J. Courey. 1999. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev. 13:2218.
25. Sun, H. T. R. 2000. Stral3 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc. Natl. Acad. Sci. USA 97:4058.
26. Bender, A., M. Sapp, G. Schuler, R. M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196:121.
27. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1994. Current Protocols in Immunology. John Wiley & Sons, New York.
28. Sadowski, I. B. Bell, P. Broad, and M. Hollis. 1992. GAL4: fusion vectors for expression in yeast or mammalian cells. Genes Chromosomes Cancer 118:137.
29. Yang, W. M., S. C. Tsai, Y. D. Wen, G. Fejer, and E. Seto. 2002. Functional domains of histone deacetylase-3. J. Biol. Chem. 277:9447.
30. Doyle, K. 1996. Protocols and Applications Guide, Vol. 1. Promega, Madison, p. 404.
31. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA pol II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
32. Tsai, S. C., N. Valkov, W. M. Yang, J. Gump, D. Sullivan, and E. Seto. 2000. Histone deacetylase interacts directly with DNA topoisomerase II. Nat. Genet. 26:349.
33. Carmen, A. A., S. E. Rundlett, and M. Grunstein. 1996. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. J. Biol. Chem. 271:15837.
34. Kozak, M. 1987. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196:947.
35. Carbone, A., G. Gaidano, A. Gloghini, L. M. Larocca, D. Capello, V. Canzonieri, A. Antinori, U. Tirelli, B. Falini, and R. Dalla-Favera. 1998. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 91:747.
36. - primary effusion lymphomas (body cavity-based lymphomas). Leukemia 12:1507.
37. Tunyaplin, C., M. A. Shapiro, and K. L. Calame. 2000. Characterization of the B lymphocyte-induced maturation protein-1 (Blimp-1) gene, mRNA isoforms and basal promoter. Nucleic Acids Res. 28:4846.
38. Liu, L., G. Shao, G. Steele-Perkins, and S. Huang. 1997. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J. Biol. Chem. 272:2984.
39. Bartholomew, C., and J. N. Ihle. 1991. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter. Mol. Cell. Biol. 11:1820.
40. Fears, S., C. Mathieu, N. Zeleznik-Le, S. Huang, J. D. Rowley, and G. Nucifora. 1996. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc. Natl. Acad. Sci. USA 93:1642.
41. Mitani, K., S. Ogawa, T. Tanaka, H. Miyoshi, M. Kurokawa, H. Mano, Y. Yazaki, M. Ohki, and H. Hirai. 1994. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13:504.
42. Ogawa, S., K. Mitani, M. Kurokawa, Y. Matsuo, J. Minowada, J. Inazawa, N. Kamada, T. Tsubota, Y. Yazaki, and H. Hirai. 1996. Abnormal expression of Evi-1 gene in human leukemias. Hum. Cell 9:323.
43. Morishita, K., E. Parganas, C. L. William, M. H. Whittaker, H. Drabkin, J. Oval, R. Taetle, M. B. Valentine, and J. N. Ihle. 1992. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc. Natl. Acad. Sci. USA 89:3937.
44. Nucifora, G., C. R. Begy, H. Kobayashi, D. Roulston, D. Claxton, J. Pedersen-Bjergaard, E. Parganas, J. N. Ihle, and J. D. Rowley. 1994. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl. Acad. Sci. USA 91:4004.
45. Cuenco, G. M., G. Nucifora, and R. Ren. 2000. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML. Proc. Natl. Acad. Sci. USA 97:1760.
46. Cigudosa, J. C., N. Z. Parsa, D. C. Louie, D. A. Filippa, S. C. Jhanwar, B. Johansson, F. Mitelman, and R. S. Chaganti. 1999. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 25:123.
47. Dave, B. J., M. M. Hess, D. L. Pickering, D. H. Zaleski, A. L. Pfeifer, D. D. Weisenburger, J. O. Armitage, and W. G. Sanger. 1999. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma. Clin. Cancer Res. 5:1401.
48. He, L., J. X. Yu, L. Liu, I. M. Buyse, M. S. Wang, Q. C. Yang, A. Nakagawara, G. M. Brodeur, Y. E. Shi, and S. Huang. 1998. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res. 58:4238.
49. Mucenski, M. L., B. A. Taylor, J. N. Ihle, J. W. Hartley, H. C. Morse III, N. A. Jenkins, and N. G. Copeland. 1988. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol. Cell. Biol. 8:301.
50. Chang, D. H., C. Angelin-Duclos, and K. Calame. 2000. BLIMP-1: trigger for differentiation of myeloid lineage. Nat. Immunol. 1:169.
51. Falini, B., M. Fizzotti, A. Pucciarini, B. Bigerna, T. Marafioti, M. Gambacorta, R. Pacini, C. Alunni, L. Natali-Tanci, B. Ugolini, C. Sebastiani, et al. 2000. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95:2084.
52. Xie, M., G. Shao, I. M. Buyse, and S. Huang. 1997. Transcriptional repression mediated by the PR domain zinc finger gene RIZ. J. Biol. Chem. 272:26360.
53. Vinatzer, U., J. Taplick, C. Seiser, C. Fonatsch, and R. Wieser. 2001. The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase. Br. J. Haematol. 114:566.
54. Jepsen, K., and M. G. Rosenfeld. 2002. Biological roles and mechanistic actions of co-repressor complexes. J. Cell Sci. 115:689.
55. Alvarez-Venegas, R., and Z. Avramova. 2002. SET-domain proteins of the Su(var)3-9, E(z) and trithorax families. Gene 285:25.
56. Kouzarides, T. 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12:198.
57. Schneider, R., A. J. Bannister, and T. Kouzarides. 2002. Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem. Sci. 27:396.
58. Rea, S., F. Eisenhaber, D. O'Carroll, B. D. Strahl, Z. W. Sun, M. Schmid, S. Opravil, K. Mechtler, C. P. Ponting, C. D. Allis, et al. 2000. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406:593.